Publications

Title

Author

Year

Impact of Community-Wide Tuberculosis Active Case Finding and Human Immunodeficiency Virus Testing on Tuberculosis Trends in Malawi.

BURKE, RM; Nliwasa, M; Dodd, PJ; FEASEY, HR A; Khundi, M; Choko, A; Nzawa-Soko, R; Mpunga, J; WEBB, EL; FIELDING, K; MacPherson, P; CORBETT, EL;

2023

Clinical infectious diseases, (2023).77 1 10.1093/cid/ciad238.

Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomise...

FOSTER, N; TADESSE, AW; MCQUAID, CF; GOSCE, L; Abdurhman, T; Assefa, D; Bedru, A; HOUBEN, RM G J; Van Kalmthout, K; Letta, T; Mohammed, Z; Van Rest, J; Umeta, DG; Weldemichael, GT; Yazew, H; Jerene, D; Quaife, M; FIELDING, KL;

2023

Trials, (2023).24 1 10.1186/s13063-023-07289-x.

Previous BCG vaccination is associated with less severe clinical progression of COVID-19.

Pereira, SM; Barreto, FR; De Souza, RA; De Souza Teles Santos, CA; Pereira, M; Da Paixão, ES; De Jesus Lima, CC O; Da Natividade, MS; Lindoso, AA B P; Fernandes, EG; Junior, EB C; PESCARINI, JM; De Andrade, KV F; De Souza, FM; De Britto, EA; Nunes, C; Ichihara, MY; Dalcolmo, M; Trajman, A; Barral-Netto, M; Abubakar, I; Barreto, ML; De Alencar Ximenes, RA; RODRIGUES, LC;

2023

BMC medicine, (2023).21 1 10.1186/s12916-023-02859-x.

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.

CLARK, RA; Mukandavire, C; Portnoy, A; WEERASURIYA, CK; Deol, A; SCARPONI, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, RC; Menzies, NA; WHITE, RG;

2023

The Lancet. Global health, (2023).11 4 10.1016/S2214-109X(23)00045-1.

Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis.

Sonnenkalb, L; Carter, JJ; Spitaleri, A; Iqbal, Z; Hunt, M; Malone, KM; Utpatel, C; Cirillo, DM; Rodrigues, C; Nilgiriwala, KS; Fowler, PW; Merker, M; Niemann, S; Comprehensive Resistance Prediction for Tuberculos,;

2023

The Lancet. Microbe, (2023).4 5 10.1016/s2666-5247(23)00002-2.

Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.

Dorward, J; Sookrajh, Y; Khubone, T; Van der Molen, J; Govender, R; Phakathi, S; Lewis, L; BOTTOMLEY, C; Maraj, M; Lessells, RJ; Naidoo, K; Butler, CC; Van Heerden, R; Garrett, N;

2023

The lancet. HIV, (2023).10 5 10.1016/S2352-3018(23)00047-4.

Transmission modeling to infer tuberculosis incidence prevalence and mortality in settings with generalized HIV epidemics.

Dodd, PJ; Shaweno, D; KU, C-C; Glaziou, P; Pretorius, C; HAYES, RJ; MacPherson, P; Cohen, T; AYLES, H;

2023

Nature communications, (2023).14 1 10.1038/s41467-023-37314-1.

TB-ML-a framework for comparing machine learning approaches to predict drug resistance of Mycobacterium tuberculosis.

Libiseller-Egger, J; Wang, L; Deelder, W; CAMPINO, S; CLARK, TG; PHELAN, JE;

2023

Bioinformatics advances, (2023).3 1 10.1093/bioadv/vbad040.

The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis.

Sossen, B; RICHARDS, AS; Heinsohn, T; Frascella, B; Balzarini, F; Oradini-Alacreu, A; Odone, A; Rogozinska, E; Häcker, B; Cobelens, F; KRANZER, K; HOUBEN, RM G J; Esmail, H;

2023

The Lancet Respiratory medicine, (2023).11 4 10.1016/S2213-2600(23)00097-8.

Post-TB Modelling.

SWEENEY, S; HOUBEN, R;

2023

(2023).